Oncology Drug Market - Global Industry Analysis

Oncology Drug Market - by Therapeutic Models (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), by Cancer Type (Breast Cancer, Blood Cancer, Prostate Cancer, Skin Cancer, Lung Cancer, Others), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast 2019 – 2026

Published Date: 25-Aug-2020 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-2871 Status : Published

Global Oncology Drug Market was valued at USD 104.7 Billion in 2019 and is expected to reach over USD 169.9 Billion by 2026, growing at a CAGR of around 7.2% during the forecast period from 2020 to 2026

Description

According to the report, the global oncology drug market was valued at USD 104.7 Billion in 2019 and is expected to reach over USD 169.9 Billion by 2026, growing at a CAGR of around 7.2% during the forecast period from 2020 to 2026.

Cancer is a class of chronic illness characterized by uncontrolled cell growth.The common types of cancer are breast cancer, cancer of the lung, colorectal cancer, uterine cancer and cancer of the thyroid.The three main drugs used for cancer are cytotoxic drugs, targeted drugs, and hormonal drugs based on their mechanism of action. The investment dynamics has increased which has propelled the growth for oncology rug market.

Oncology Drug Market: Overview

Oncology is a branch of therapeutic science that study malignancy and treatment and prevention of malignancy. Segments of oncology include radiation oncology (the use of radiation therapy to treat cancer), medical oncology (the use of chemotherapy, hormone therapy and other drugs to treat cancer), and surgical oncology (the use of surgeries to treat cancer).

Cancer is the uncontrolled growth of abnormal cells anywhere in an individual’s body. These cells are termed as tumor cells or malignant cells. Frequently, cancer cells can detach from this original mass of cells, travel along the blood and lymph systems, and lodge in other organs where they can repeat the uncontrolled growth cycle. This process of cancer cells, leaving an area and growing in another area of the body is termed as metastatic spread or metastasis.

Cancer stage is often determined by biopsy results which also helps to determine the cancer type and the extent to which cancer has spread in an individual. Staging also helps doctors to determine treatment protocols. 

Oncology Drug Market: Market Dynamics

Major drivers in the oncology drug market include growing prevalence of various types of cancer, increasing demand of biological and targeted drug therapies, technological advancements in the healthcare sector, continuous patent expiry of key cancer drugs, rise in need for R&D activities in cancer, growing concerns over high death rates due to cancer and the rising impact of biosimilars.

The threat of failure and the adverse effects of cancer drug therapy; particularly chemotherapy, strict government regulations, the high cost of drug development is expected to hinder the growth of the global oncology drugs market over the forecast period.

Oncology treatments are rapidly evolving with the latest innovations emerging from immunotherapy research, thus creating new grounds for R&D for the competing firms, cancer vaccines is also seeing a genetic engineering of living immune cells and reinfusing them into cancer patients, re-emerged when combined with checkpoint inhibitors, yet another kind of immunotherapy, is swiftly advancing. The recent discovery of genes linked to ovarian cancer risk (RAD51C and RAD51D0), new pancreatic cancer susceptibility genes (CDKN2A, BRCA1/2, PALB2), and the discovery that many cases of pediatric cancer are associated with hereditary gene mutations, may lead to new kinds of targeted therapies.

Segmentation based on the Therapeutic Modals:

  • Chemotherapy
  • Targeted therapy
  • Immunotherapy
  • Hormonal therapy
  • Others

Segmentation based on the Cancer Type:

  • Breast cancer
  • Blood cancer
  • Prostate cancer

Gastrointestinal tract cancer

  • Skin cancer
  • Lung cancer
  • Others

Segmentation based on Regions:

North America dominates the oncology drug market over the forecast period, attributed to high presence of the cancer drugs development companies in the U.S. Additionally, high disposable incomes of consumers and compulsory health insurance cover for life-threatening diseases leads to increasing the affordability of cancer treatment in the U.S. Europe is the second largest revenue generating region in oncology drugs market over the forecast period.  The research for cancer drugs in developing economies including Asia Pacific, Latin America, and the Middle East and Africa is emerging with the focus towards the development of biosimilars. The prevalence of various cancer types is high in developing countries which generates interest for these regions to conduct clinical trials. In addition, the cost of research is low in these regions due to favorable government policies and the availability of a huge population base contributing to the oncology drug market growth in the developing countries. This, in turn, results in the significant growth of oncology drug market in the developing region over the forecast period.

Oncology Drug Market: Competitors

Some of the key players in the global oncology drug market include Johnson & Johnson, Amgen Inc., Eli lilly & Co., GlaxoSmithKline, Roche diagnostics, Merck & Co., Pfizer, Sanofi, and Celgene Corporation, and Novartis AG.

Global Heat Stabilizer Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

  • Chapter 1 Preface
    • 1.1 Report Description
    • 1.1 Report Scope
  • Chapter 2 Research Methodology
    • 2.1 Research Methodology
    • 2.2 Secondary Research
    • 2.3 Primary Research
    • 2.4 Models
      • 2.4.1 Company Share Analysis Model
      • 2.4.2 Revenue Based Modelling
    • 2.5 Research Limitations
  • Chapter 3 Executive Summary
    • 3.1 Global Onculogy Drug Market, 2016 – 2026 (USD Million)
    • 3.2 Global Onculogy Drug Market: Snapshot
  • Chapter 4 Onculogy Drug Market – Industry Analysis
    • 4.1 Introduction
    • 4.2 Market Drivers
      • 4.2.1 Driving Factor 1 Analysis
      • 4.2.2 Driving Factor 2 Analysis:
    • 4.3 Market Restraints
      • 4.3.1 Restraining Factor Analysis
    • 4.4 Market Opportunities
      • 4.4.1 Market Opportunity & Use-case Analysis
      • 4.4.2 Use – Cases for Onculogy Drug
    • 4.5 Porter’s Five Forces Analysis
    • 4.6 COVID 19 Impact Analysis
      • 4.6.1.1 Impact on Product Development and Technology Adoption
      • 4.6.1.2 Gap Analysis
  • Chapter 5 Investment Proposition Analysis
    • 5.1 Global Onculogy Drug Market Attractiveness, By Therapeutic Models
    • 5.2 Global Onculogy Drug Market Attractiveness, By Cancer Type
    • 5.3 Global Onculogy Drug Market Attractiveness, By Region
  • Chapter 6 Competitive Landscape
    • 6.1 Company Market Share Analysis - 2019
      • 6.1.1 Global Onculogy Drug Market: Company Market Share, 2019
    • 6.2 Strategic Developments
    • 7.1 Global Onculogy Drug Market Overview: By Therapeutic Models
      • 7.1.1 Global Onculogy Drug Market Revenue Share, By Therapeutic Models, 2019 & 2026
    • 7.2 Global Onculogy Drug Market Analysis/Overview – By Therapeutic Models
      • 7.2.1 Chemotherapy – Overview/Analysis
      • 7.2.2 Targeted Therapy – Overview/Analysis
      • 7.2.3 Immunotherapy – Overview/Analysis
      • 7.2.4 Hormonal Therapy – Overview/Analysis
      • 7.2.5 Others – Overview/Analysis
    • 7.3 Chemotherapy
      • 7.3.1 Global Onculogy Drug Market for Chemotherapy, Revenue (USD Million) 2016 - 2026
    • 7.4 Targeted Therapy
      • 7.4.1 Global Onculogy Drug Market for Targeted Therapy, Revenue (USD Million) 2016 - 2026
    • 7.5 Immunotherapy
      • 7.5.1 Global Onculogy Drug Market for Immunotherapy, Revenue (USD Million) 2016 - 2026
    • 7.6 Hormonal Therapy
      • 7.6.1 Global Onculogy Drug Market for Hormonal Therapy, Revenue (USD Million) 2016 - 2026
    • 7.7 Others
      • 7.7.1 Global Onculogy Drug Market for Others, Revenue (USD Million) 2016 - 2026
    • 8.1 Global Onculogy Drug Market Overview: By Cancer Type
      • 8.1.1 Global Onculogy Drug Market Revenue Share, By Cancer Type, 2019 & 2026
    • 8.2 Global Onculogy Drug Market Analysis/Overview – By Cancer Type
      • 8.2.1 Breast Cancer – Overview/Analysis
      • 8.2.2 Blood Cancer – Overview/Analysis
      • 8.2.3 Prostate Cancer – Overview/Analysis
      • 8.2.4 Skin Cancer – Overview/Analysis
      • 8.2.5 Lung Cancer – Overview/Analysis
      • 8.2.6 Others – Overview/Analysis
    • 8.3 Breast Cancer
      • 8.3.1 Global Onculogy Drug Market for Breast Cancer, Revenue (USD Million) 2016 - 2026
    • 8.4 Blood Cancer
      • 8.4.1 Global Onculogy Drug Market for Blood Cancer, Revenue (USD Million) 2016 - 2026
    • 8.5 Prostate Cancer
      • 8.5.1 Global Onculogy Drug Market for Prostate Cancer, Revenue (USD Million) 2016 - 2026
    • 8.6 Skin Cancer
      • 8.6.1 Global Onculogy Drug Market for Skin Cancer, Revenue (USD Million) 2016 - 2026
    • 8.7 Lung Cancer
      • 8.7.1 Global Onculogy Drug Market for Lung Cancer, Revenue (USD Million) 2016 - 2026
    • 8.8 Others
      • 8.8.1 Global Onculogy Drug Market for Others, Revenue (USD Million) 2016 - 2026
  • Chapter 9 Onculogy Drug Market – Regional Analysis
    • 9.1 Global Onculogy Drug Market: Regional Overview
      • 9.1.1 Global Onculogy Drug Market Revenue Share, by Region, 2019 & 2026
      • 9.1.2 Global Onculogy Drug Market Revenue, by Region, 2016 – 2026 (USD Million)
    • 9.2 North America
      • 9.2.1 North America Onculogy Drug Market Revenue, 2016 - 2026 (USD Million)
      • 9.2.2 North America Onculogy Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.2.3 North America Onculogy Drug Market Revenue, By Therapeutic Models, 2016 – 2026
      • 9.2.4 North America Onculogy Drug Market Revenue, By Cancer Type, 2016 – 2026
      • 9.2.5 U.S.
      • 9.2.6 Canada
    • 9.3 Europe
      • 9.3.1 Europe Onculogy Drug Market Revenue, 2016 - 2026 (USD Million)
      • 9.3.2 Europe Onculogy Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.3.3 Europe Onculogy Drug Market Revenue, By Therapeutic Models, 2016 – 2026
      • 9.3.4 Europe Onculogy Drug Market Revenue, By Cancer Type, 2016 – 2026
      • 9.3.5 Germany
      • 9.3.6 France
      • 9.3.7 U.K.
      • 9.3.8 Rest of Europe
    • 9.4 Asia Pacific
      • 9.4.1 Asia Pacific Onculogy Drug Market Revenue, 2016 - 2026 (USD Million)
      • 9.4.2 Asia Pacific Onculogy Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.4.3 Asia Pacific Onculogy Drug Market Revenue, By Therapeutic Models, 2016 – 2026
      • 9.4.4 Asia Pacific Onculogy Drug Market Revenue, By Cancer Type, 2016 – 2026
      • 9.4.5 China
      • 9.4.6 Japan
      • 9.4.7 India
      • 9.4.8 Rest of Asia Pacific
    • 9.5 Latin America
      • 9.5.1 Latin America Onculogy Drug Market Revenue, 2016 - 2026 (USD Million)
      • 9.5.2 Latin America Onculogy Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.5.3 Latin America Onculogy Drug Market Revenue, By Therapeutic Models, 2016 – 2026
      • 9.5.4 Latin America Onculogy Drug Market Revenue, By Cancer Type, 2016 – 2026
      • 9.5.5 Brazil
      • 9.5.6 Rest of Latin America
    • 9.6 The Middle-East and Africa
      • 9.6.1 The Middle-East and Africa Onculogy Drug Market Revenue, 2016 - 2026 (USD Million)
      • 9.6.2 The Middle-East and Africa Onculogy Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.6.3 The Middle-East and Africa Onculogy Drug Market Revenue, By Therapeutic Models, 2016 – 2026
      • 9.6.4 The Middle-East and Africa Onculogy Drug Market Revenue, By Cancer Type, 2016 – 2026
      • 9.6.5 GCC Countries
      • 9.6.6 Rest of Middle-East Africa
  • Chapter 10 Company Profiles
    • 10.1 Johnson & Johnson
      • 10.1.1 Company Overview
      • 10.1.2 Financial Overview
      • 10.1.3 Product Portfolio
      • 10.1.4 Business Strategy
      • 10.1.5 Recent Developments
    • 10.2 Amgen Inc.
    • 10.3 Eli Lilly Co.
    • 10.4 GSK
    • 10.5 Roche Diagnostics
    • 10.6 Merck & Co.
    • 10.7 Pfizer
    • 10.8 Sanofi
    • 10.9 Novartis AG
    • 10.10 Celgene Corporation

Table Of Figures

List of Figures 

FIG. 1 Research Methodology
FIG. 2 Research Methodology – Basic Overview
FIG. 3 Research Methodology – Detailed View
FIG. 4 Global Oncology Drug Market Revenue, 2016 - 2026 (USD Million)
FIG. 5 Porter’s Five Forces Analysis for Global Oncology Drug Market
FIG. 6 Global Oncology Drug Market Attractiveness, By Therapeutic Models
FIG. 7 Global Oncology Drug Market Attractiveness, By Cancer Type
FIG. 8 Global Oncology Drug Market Attractiveness, By End-User
FIG. 9 Company Share Analysis, 2019
FIG. 10 Global Oncology Drug Market Revenue Share, By Therapeutic Models, 2019 & 2026
FIG. 11 Global Oncology Drug Market for Chemotherapy, Revenue (USD Million) 2016 - 2026
FIG. 12 Global Oncology Drug Market for Targeted Therapy, Revenue (USD Million) 2016 - 2026
FIG. 13 Global Oncology Drug Market for Immunotherapy, Revenue (USD Million) 2016 - 2026
FIG. 14 Global Oncology Drug Market for Hormonal Therapy, Revenue (USD Million) 2016 - 2026
FIG. 15 Global Oncology Drug Market for Others, Revenue (USD Million) 2016 - 2026
FIG. 16 Global Oncology Drug Market Revenue Share, By Cancer Type, 2019 & 2026
FIG. 17 Global Oncology Drug Market for Breast Cancer, Revenue (USD Million) 2016 - 2026
FIG. 18 Global Oncology Drug Market for Blood Cancer, Revenue (USD Million) 2016 - 2026
FIG. 19 Global Oncology Drug Market for Prostate Cancer, Revenue (USD Million) 2016 - 2026
FIG. 20 Global Oncology Drug Market for Skin Cancer, Revenue (USD Million) 2016 - 2026
FIG. 21 Global Oncology Drug Market for Lung Cancer, Revenue (USD Million) 2016 - 2026
FIG. 22 Global Oncology Drug Market for Others, Revenue (USD Million) 2016 - 2026
FIG. 23 Global Oncology Drug Market Revenue Share, by Region, 2019 & 2026
FIG. 24 North America Oncology Drug Market Revenue, 2016 - 2026 (USD Million)
FIG. 25 Europe Oncology Drug Market Revenue, 2016 - 2026 (USD Million)
FIG. 26 Asia Pacific Oncology Drug Market Revenue, 2016 - 2026 (USD Million)
FIG. 27 Latin America Oncology Drug Market Revenue, 2016 - 2026 (USD Million)
FIG. 28 The Middle-East and Africa Oncology Drug Market Revenue, 2016 - 2026 (USD Million)
FIG. 29 Johnson & Johnson Business Segment Revenue Share, 2018 (%)
FIG. 30 Johnson & Johnson Geographical Segment Revenue Share, 2018 (%)


Table Of Tables

List of Tables

TABLE 1 Global Oncology Drug Market: Snapshot
TABLE 2 Drivers of the Oncology Drug Market: Impact Analysis
TABLE 3 Restraints for the Oncology Drug Market: Impact Analysis
TABLE 4 Global Oncology Drug Market Revenue, by Region, 2016 – 2026 (USD Million)
TABLE 5 North America Oncology Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 6 North America Oncology Drug Market Revenue, By Therapeutic Models, 2016 – 2026 (USD Million)
TABLE 7 North America Oncology Drug Market Revenue, By Cancer Type, 2016 – 2026 (USD Million)
TABLE 8 Europe Oncology Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 9 Europe Oncology Drug Market Revenue, By Therapeutic Models, 2016 – 2026 (USD Million)
TABLE 10 Europe Oncology Drug Market Revenue, By Cancer Type, 2016 – 2026 (USD Million)
TABLE 11 Asia Pacific Oncology Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 12 Asia Pacific Oncology Drug Market Revenue, By Therapeutic Models, 2016 – 2026 (USD Million)
TABLE 13 Asia Pacific Oncology Drug Market Revenue, By Cancer Type, 2016 – 2026 (USD Million)
TABLE 14 Latin America Oncology Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 15 Latin America Oncology Drug Market Revenue, By Therapeutic Models, 2016 – 2026 (USD Million)
TABLE 16 Latin America Oncology Drug Market Revenue, By Cancer Type, 2016 – 2026 (USD Million)
TABLE 17 The Middle-East and Africa Oncology Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 18 The Middle-East and Africa Oncology Drug Market Revenue, By Therapeutic Models, 2016 – 2026 (USD Million)
TABLE 19 The Middle-East and Africa Oncology Drug Market Revenue, By Cancer Type, 2016 – 2026 (USD Million)

Methodology

Choose License Type

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed